Cargando…

Is heterologous prime-boost COVID-19 vaccination a concern or an opportunity for Ethiopia?

Detalles Bibliográficos
Autores principales: Gelanew, Tesfaye, Wassie, Liya, Mulu, Andargachew, Wondwossen, Liya, Abebe, Markos, Mihret, Adane, Abdissa, Alemseged
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9909475/
https://www.ncbi.nlm.nih.gov/pubmed/36777764
http://dx.doi.org/10.3389/fpubh.2022.1046546
_version_ 1784884582867271680
author Gelanew, Tesfaye
Wassie, Liya
Mulu, Andargachew
Wondwossen, Liya
Abebe, Markos
Mihret, Adane
Abdissa, Alemseged
author_facet Gelanew, Tesfaye
Wassie, Liya
Mulu, Andargachew
Wondwossen, Liya
Abebe, Markos
Mihret, Adane
Abdissa, Alemseged
author_sort Gelanew, Tesfaye
collection PubMed
description
format Online
Article
Text
id pubmed-9909475
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-99094752023-02-10 Is heterologous prime-boost COVID-19 vaccination a concern or an opportunity for Ethiopia? Gelanew, Tesfaye Wassie, Liya Mulu, Andargachew Wondwossen, Liya Abebe, Markos Mihret, Adane Abdissa, Alemseged Front Public Health Public Health Frontiers Media S.A. 2023-01-26 /pmc/articles/PMC9909475/ /pubmed/36777764 http://dx.doi.org/10.3389/fpubh.2022.1046546 Text en Copyright © 2023 Gelanew, Wassie, Mulu, Wondwossen, Abebe, Mihret and Abdissa. https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Public Health
Gelanew, Tesfaye
Wassie, Liya
Mulu, Andargachew
Wondwossen, Liya
Abebe, Markos
Mihret, Adane
Abdissa, Alemseged
Is heterologous prime-boost COVID-19 vaccination a concern or an opportunity for Ethiopia?
title Is heterologous prime-boost COVID-19 vaccination a concern or an opportunity for Ethiopia?
title_full Is heterologous prime-boost COVID-19 vaccination a concern or an opportunity for Ethiopia?
title_fullStr Is heterologous prime-boost COVID-19 vaccination a concern or an opportunity for Ethiopia?
title_full_unstemmed Is heterologous prime-boost COVID-19 vaccination a concern or an opportunity for Ethiopia?
title_short Is heterologous prime-boost COVID-19 vaccination a concern or an opportunity for Ethiopia?
title_sort is heterologous prime-boost covid-19 vaccination a concern or an opportunity for ethiopia?
topic Public Health
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9909475/
https://www.ncbi.nlm.nih.gov/pubmed/36777764
http://dx.doi.org/10.3389/fpubh.2022.1046546
work_keys_str_mv AT gelanewtesfaye isheterologousprimeboostcovid19vaccinationaconcernoranopportunityforethiopia
AT wassieliya isheterologousprimeboostcovid19vaccinationaconcernoranopportunityforethiopia
AT muluandargachew isheterologousprimeboostcovid19vaccinationaconcernoranopportunityforethiopia
AT wondwossenliya isheterologousprimeboostcovid19vaccinationaconcernoranopportunityforethiopia
AT abebemarkos isheterologousprimeboostcovid19vaccinationaconcernoranopportunityforethiopia
AT mihretadane isheterologousprimeboostcovid19vaccinationaconcernoranopportunityforethiopia
AT abdissaalemseged isheterologousprimeboostcovid19vaccinationaconcernoranopportunityforethiopia